MedTrace Logo

Efficacy of Light Therapy Device LUMINETTE® in Major Depressive Disorder

NCT03685942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-08-21

No results posted yet for this study

Summary

This study evaluates the addition of light therapy with LUMINETTE device to usual treatment (antidepressant drug and psychotherapy) in the treatment of Major Depressive Disorder (MDD). Half of the participants will receive active light therapy with LUMINETTE device while the other half will receive placebo light therapy with LUMINETTE placebo device.

Conditions

Interventions

DEVICE

active light therapy (LUMINETTE®)

light therapy on a portable light visor device

DEVICE

placebo light therapy

placebo portable light visor device

Sponsors & Collaborators

  • LUCIMED

    collaborator UNKNOWN

  • Centre Psychothérapique de Nancy

    lead OTHER

Principal Investigators

  • Thomas SCHWITZER · Centre Psychothérapique de Nancy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2023-09-08
Completion
2023-09-08

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685942 on ClinicalTrials.gov